Andrew W Roberts

39PUBLICATIONS
122CO-AUTHORS
HaematologyHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (39)

|Jan 01, 2026
Blood: flowing stronger than ever after 80 years.

Andrew W Roberts

|May 28, 2025
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer.

Ing S Tiong, Tamia Nguyen, Chong C Chua

|Apr 09, 2025
Re-appraising assays on permeabilized blood cancer cells testing venetoclax or other BH3 mimetic agents selectively targeting pro-survival BCL2 proteins.

Jia-Nan Gong, Tirta M Djajawi, Donia M Moujalled

|Jan 18, 2025
Final analysis of the phase 1b Chemotherapy and Venetoclax in Elderly Acute Myeloid Leukemia Trial (CAVEAT).

Chong Chyn Chua, Sun Loo, Chun Yew Fong

|Jan 10, 2025
Single-cell Rapid Capture Hybridization sequencing reliably detects isoform usage and coding mutations in targeted genes.

Hongke Peng, Jafar S Jabbari, Luyi Tian

|Oct 29, 2024
Venetoclax dose escalation rapidly activates a BAFF/BCL-2 survival axis in chronic lymphocytic leukemia.

Meng-Xiao Luo, Tania Tan, Marie Trussart

Pageof 7

Frequent Collaborators

13 joint publications

Xin Huang

12 joint publications

John F Seymour

8 joint publications

Constantine S Tam

7 joint publications

Andrew H Wei